Literature DB >> 16601360

Metallothionein isoform 3 gene is differentially expressed in corticotropin-producing pituitary adenomas.

R R Giorgi1, M L C Correa-Giannella, A P M Casarini, M C Machado, M D Bronstein, V A Cescato, D Giannella-Neto.   

Abstract

In order to search for candidate genes related to pituitary adenoma aggressiveness, the present investigation was intended to compare the mRNA expression profile from a pool of four nonfunctional pituitary adenomas (NFPA) with a spinal cord metastasis of a nonfunctional pituitary carcinoma (MNFPC). The metallothionein isoform 3 (MT3) gene was differentially expressed in nonfunctional adenomas in comparison to the metastasis of nonfunctional carcinoma. A microarray dataset comprising 19,881 probes was employed for comparing expression profiles of a spinal cord metastasis of a nonfunctional pituitary carcinoma with a pool of four nonfunctional pituitary adenomas. RT-qPCR confirmed the microarray findings and was used to investigate MT3 mRNA gene expression in tumor samples of a series of 52 different pituitary adenoma subtypes comprising 10 corticotropin (ACTH)-producing, 18 growth hormone (GH)-producing, 8 prolactin (PRL)-producing, and 16 nonfunctional adenomas. Microarray data analysis by GeneSifter program unveiled Gene Ontology terms related to zinc ion-binding activity closely related to MT3 function. MT3 mRNA expression was statistically significantly higher in ACTH-producing pituitary adenomas and in nonfunctional pituitary adenomas in comparison to the other pituitary adenoma subtypes. The more abundant expression of this gene in ACTH-producing pituitary adenomas suggests that MT3 could be related to distinct pituitary cell lineage regulating the activity of some transcription factor of importance in hormone production and/or secretion.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16601360     DOI: 10.1159/000092521

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  9 in total

1.  Expression of CRABP1, GRP, and RERG mRNA in clinically non-functioning and functioning pituitary adenomas.

Authors:  T Chile; M L Corrêa-Giannella; M A H Z Fortes; M D Bronstein; M B Cunha-Neto; D Giannella-Neto; R R Giorgi
Journal:  J Endocrinol Invest       Date:  2011-01-26       Impact factor: 4.256

2.  Matrix metalloproteinase-9 is differentially expressed in nonfunctioning invasive and noninvasive pituitary adenomas and increases invasion in human pituitary adenoma cell line.

Authors:  Isa M Hussaini; Christy Trotter; Yunge Zhao; Rana Abdel-Fattah; Samson Amos; Aizhen Xiao; Crystal U Agi; Gerard T Redpath; Zixing Fang; Gilberto K K Leung; Maria Beatriz S Lopes; Edward R Laws
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

3.  Identification of growth arrest and DNA-damage-inducible gene beta (GADD45beta) as a novel tumor suppressor in pituitary gonadotrope tumors.

Authors:  Katherine A Michaelis; Aaron J Knox; Mei Xu; Katja Kiseljak-Vassiliades; Michael G Edwards; Mark Geraci; B K Kleinschmidt-DeMasters; Kevin O Lillehei; Margaret E Wierman
Journal:  Endocrinology       Date:  2011-08-02       Impact factor: 4.736

Review 4.  Isolation and characterization of novel pituitary tumor related genes: a cDNA representational difference approach.

Authors:  Xun Zhang; Yunli Zhou; Anne Klibanski
Journal:  Mol Cell Endocrinol       Date:  2010-03-06       Impact factor: 4.102

5.  An early requirement for maternal FoxH1 during zebrafish gastrulation.

Authors:  Wuhong Pei; Houtan Noushmehr; Justin Costa; Maia V Ouspenskaia; Abdel G Elkahloun; Benjamin Feldman
Journal:  Dev Biol       Date:  2007-07-19       Impact factor: 3.582

6.  A technique of mRNA extraction and labeling from circulating lymphocytes of children treated with growth hormone replacement therapy for microarray analysis.

Authors:  M Camilot; F Teofoli; S Longobardi; A Gandini; C Lievore; S Lauriola; L Tatò
Journal:  J Endocrinol Invest       Date:  2008-01       Impact factor: 4.256

7.  Metallothionein-3 (MT-3) in the human adrenal cortex and its disorders.

Authors:  Saulo J A Felizola; Yasuhiro Nakamura; Yuki Arata; Kazue Ise; Fumitoshi Satoh; William E Rainey; Sanae Midorikawa; Shinichi Suzuki; Hironobu Sasano
Journal:  Endocr Pathol       Date:  2014-09       Impact factor: 3.943

Review 8.  Genetic aspects of pituitary carcinoma: A systematic review.

Authors:  Zijiang Yang; Ting Zhang; Heng Gao
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

Review 9.  The roles of metallothioneins in carcinogenesis.

Authors:  Manfei Si; Jinghe Lang
Journal:  J Hematol Oncol       Date:  2018-08-23       Impact factor: 17.388

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.